Hsbc Holdings PLC Neogenomics Inc Transaction History
Hsbc Holdings PLC
- $159 Billion
- Q1 2025
A detailed history of Hsbc Holdings PLC transactions in Neogenomics Inc stock. As of the latest transaction made, Hsbc Holdings PLC holds 18,769 shares of NEO stock, worth $140,767. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,769
Previous 29,569
36.52%
Holding current value
$140,767
Previous $487,000
63.45%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding NEO
# of Institutions
288Shares Held
127MCall Options Held
942KPut Options Held
172K-
Black Rock Inc. New York, NY19.7MShares$148 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.3MShares$107 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny6.72MShares$50.4 Million0.04% of portfolio
-
First Light Asset Management, LLC Edina, MN6.04MShares$45.3 Million7.36% of portfolio
-
Janus Henderson Group PLC London, X05.74MShares$43.1 Million0.03% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $943M
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...